Press Resease

Defibrillators Market - Global Industry Analysis

Defibrillators Market By Product (Implantable Cardioverter Defibrillators and External Defibrillators), By End User (Hospitals, Clinics and Cardiac Centers, Prehospital Care Settings, Public Access Markets, Home Care Settings and Alternate Care Facilities) and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 08-Oct-2021 Category: Medical Device Report Format : PDF Pages: 160 Report Code: ZMR-982 Status : Published

The global Defibrillators market accounted for USD 9,714.6 Million in 2020 and is expected to reach USD 12,552.2 Million by 2028, growing at a CAGR of 3.5% from 2021 to 2028.

Description

Market Overview

The global Defibrillators market accounted for USD 9,714.6Million in 2020 and is expected to reach USD 12,552.2 Million by2028, growing at a CAGR of 3.5% from 2021 to 2028.

Defibrillators can be simply described as electronic devicesthat deliver an electric shock, of high energy, to the heart of anindividual, who went into cardiac arrest. They restore the normalcardiac rhythm of the heart. They are predominantly used to corrector prevent an arrhythmia, which can be simply defined as aheartbeat that is too slow or too fast. There are several types ofDefibrillators and based on their type, they show a different modeof operation.

Cardiovascular diseases have risen the morbidity ratesignificantly. Increased morbidity rate is one of the key factorsthat is augmenting the global defibrillators market. The ability ofDefibrillators to efficiently control arrhythmias, for extendedperiods, will drive the growth for Defibrillators market, duringthe forecast period.

Global Defibrillators Market Size

COVID-19 Impact Analysis

Before the COVID-19 pandemic, companies in the defibrillatorsmarket were expanding at a steady pace. However, during thepandemic, the players in the market took a sharp hit. This can beaccredited to the worldwide lockdown and the widespread infectionrate of the virus.

Due to the lockdown, the cardiac procedures that were classifiedas elective were pushed forward, indefinitely. Additionally,hospitals did not take on patients for surgical procedures due tothe high risk of infection. All these factors had a cumulativeimpact on the Defibrillators market, which declinedsignificantly.

However, the pandemic also highlighted the significance ofhealth awareness. Furthermore, Defibrillators will be used insevere cases of Covid infection, to help patients who undergocardiac arrest. This will enhance the defibrillators market, in thecoming years.

Growth Factors

Increased health awareness, changing demographics and risingprevalence of cardiovascular diseases are some of the key factorsthat advance the defibrillators market.

The world population, currently, is struggling withnon-communicable diseases such as cardiovascular diseases, obesityrelated disorders, diabetes and hypertension among others. Thesediseases have a negative impact on the cardiac health ofindividuals. Owing to this, there is an increase in cardiacsurgeries and procedures. This will drive the growth ofDefibrillators market. Furthermore, changing demographics haveincreased the population of aging citizens. This further increasesthe demand and need for cardiac procedures.

Subsequently, the presence of large number of developing anddeveloped economies, worldwide, have resulted in economic growthand high disposable incomes. Owing to this, the expenditure powerof consumers has risen, which will further enhance theDefibrillators market.

Report Scope:

Report AttributeDetails
Base Year2020
Historic Years2016 - 2020
Forecast Years2021 - 2028
Segments CoveredBy Product Type, By Application, and By End Use
Forecast UnitsValue (USD Billion), and Volume (Units)
Quantitative UnitsRevenue in USD million/billion and CAGR from 2021 to 2028
Regions CoveredNorth America, Europe, Asia Pacific, Latin America, and MiddleEast & Africa, and Rest of World
Countries CoveredU.S., Canada, Mexico, U.K., Germany, France, Italy, Spain,China, India, Japan, South Korea, Brazil, Argentina, GCC Countries,and South Africa, among others
Companies CoveredBoston Scientific Corporation, Medtronic Plc, AbbottLaboratories, Nihon Kohden Corporation, Koninklijke Philips N.V.,Biotronik, LivaNova Plc, Mediana Co. Ltd., BPL Medical Technologiesand Schiller AG among others
Report CoverageMarket growth drivers, restraints, opportunities, Porter’s fiveforces analysis, PEST analysis, value chain analysis, regulatorylandscape, market attractiveness analysis by segments and region,company market share analysis, and COVID-19 impact analysis.
Customization ScopeAvail customized purchase options to meet your exact researchneeds.

Product Segment Analysis Preview

The Implantable Cardioverter Defibrillators (ICDs) segment helda share of over 36% in 2020, becoming the most dominant segment,globally and it is expected to maintain its dominance, during theforecast period. This dominance can be credited to several factorssuch as increasing technological developments, rising research anddevelopment activities and the advantages linked with the usage ofICDs.

Owing to economic growth, large investments for research anddevelopment activities, in the healthcare segment and technologicaldevelopments, ICDs have been modified and developed, to providevalue to the end-users, efficiently. Due to this, they acquire amajor part of the global Defibrillators market.

Subsequently, the External Defibrillators segment holds asubstantial share of the market. This is attributable to thefeatures of Wearable Cardioverter Defibrillators (WCDs) andAutomated External Defibrillators (AEDs). Due to their automation,they can be easily operated, with convenience.

Global Defibrillators Market Share

End User Segment Analysis Preview

The Hospitals, Clinics and Cardiac Centers segment isanticipated to reach a CAGR of over 2.5% between 2021 and 2028.This is attributable to the immense demand and usage ofDefibrillators at Hospitals and Clinics.  

Defibrillators are utilized for a multitude of cardiac surgeriesand procedures. They have applications outside of cardiac surgeryas well. With rising healthcare segment and increased expenditurepower, there has been a surge in elective procedures and surgeries.This, in turn, enhances the use of Defibrillators at Hospitals.Additionally, sedentary lifestyles increase the burden ofcardiovascular diseases. Subsequently, the Public Access Marketssegment holds a substantial share of the Defibrillators market.This is attributable to the increased prevalence of heartconditions. Setting up of Defibrillators at Public places helpswith cardiac arrest occurrences at Public locations.

Regional Analysis Preview

The North America region accounted for a share of over 33% in2020. This is attributable to various factors such as innovationsin the field of healthcare and devices, enhanced obesity rate,well-established and advanced healthcare system and high prevalenceof cardiovascular diseases, in the region.

Developed economies like the US and Canada have well-establishedand highly advanced healthcare systems. Due to this, they havelarge number of investments in the medical industry, for developingand innovating surgical procedures. This advances theDefibrillators market in the region. Additionally, the obesity rateof the region is on the rise. This creates health problems for itsresidents and increases their reliability on medical procedures.Furthermore, the region has a high prevalence rate ofcardiovascular diseases. This, in turn, enhances the growth ofDefibrillators market, in the region.

Global Defibrillators Market Regional Analysis

The Asia Pacific region is anticipated to grow with a CAGR ofover 6.7% between 2021 and 2028. This can be accredited to severalfactors that include economic development, growing population,advancing healthcare segment and changing demographics, in theregion.

Countries like Japan, China and India have a rapidly growinghealthcare system. Additionally, governments across variouscountries in the Asia Pacific region are taking initiatives andmaking huge investments in their healthcare system, to enhancetheir medical care and facilities.

Furthermore, the region is undergoing a change in theirdemographics which has increased the population of aging citizens.Subsequently, there is increased health awareness and enhancedexpenses in the healthcare and medical industry, in the region.This will further enhance the regional Defibrillators market. 

Key Market Players & Competitive Landscape

Some of the key players in the Defibrillators market are BostonScientific Corporation, Medtronic Plc, Abbott Laboratories, NihonKohden Corporation, Koninklijke Philips N.V., Biotronik, LivaNovaPlc, Mediana Co. Ltd., BPL Medical Technologies and Schiller AGamong others.

The global Defibrillators Market is segmented as follows:

By Product

  • Implantable Cardioverter Defibrillators (ICDs)
    • Transvenous Implantable Cardioverter Defibrillators(T-ICDs)
    • Subcutaneous Implantable Cardioverter Defibrillators(S-ICDs)
    • Cardiac Resynchronization Therapy Defibrillator (CRT-D)
  • External Defibrillators
    • Manual External Defibrillators (MEDs)
    • Automated External Defibrillators (AEDs)
    • Wearable Cardioverter Defibrillators (WCDs)

By End User

  • Hospitals, Clinics and Cardiac Centers
  • Prehospital Care Settings
  • Public Access Markets
  • Home Care Settings
  • Alternate Care Facilities

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Product
        • 2.1.1.2. Market Attractiveness Analysis, By End User
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Defibrillators Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast By Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Defibrillators Market – Product Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
    • 4.2. Implantable Cardioverter Defibrillators (ICDs)
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. External Defibrillators
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Defibrillators Market – End User Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By End User, 2020 & 2028
    • 5.2. Hospitals, Clinics and Cardiac Centers
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Prehospital Care Settings
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Public Access Markets
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Home Care Settings
      • 5.5.1. Market Size and Forecast, By Region (USD Million)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Alternate Care Facilities
      • 5.6.1. Market Size and Forecast, By Region (USD Million)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Defibrillators Market – Regional Analysis
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.2.2. North America Market Revenue, By Product, 2016 – 2028
      • 6.2.3. North America Market Revenue, By End User, 2016 – 2028
      • 6.2.4. U.S.
        • 6.2.4.1. U.S. Market Revenue, By Product, 2016 – 2028
        • 6.2.4.2. U.S. Market Revenue, By End User, 2016 – 2028
      • 6.2.5. Canada
        • 6.2.5.1. Canada Market Revenue, By Product, 2016 – 2028
        • 6.2.5.2. Canada Market Revenue, By End User, 2016 – 2028
      • 6.2.6. Mexico
        • 6.2.6.1. Mexico Market Revenue, By Product, 2016 – 2028
        • 6.2.6.2. Mexico Market Revenue, By End User, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.3.2. Europe Market Revenue, By Product, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By End User, 2016 – 2028
      • 6.3.4. Germany
        • 6.3.4.1. Germany Market Revenue, By Product, 2016 – 2028
        • 6.3.4.2. Germany Market Revenue, By End User, 2016 – 2028
      • 6.3.5. France
        • 6.3.5.1. France Market Revenue, By Product, 2016 – 2028
        • 6.3.5.2. France Market Revenue, By End User, 2016 – 2028
      • 6.3.6. U.K.
        • 6.3.6.1. U.K. Market Revenue, By Product, 2016 – 2028
        • 6.3.6.2. U.K. Market Revenue, By End User, 2016 – 2028
      • 6.3.7. Italy
        • 6.3.7.1. Italy Market Revenue, By Product, 2016 – 2028
        • 6.3.7.2. Italy Market Revenue, By End User, 2016 – 2028
      • 6.3.8. Spain
        • 6.3.8.1. Spain Market Revenue, By Product, 2016 – 2028
        • 6.3.8.2. Spain Market Revenue, By End User, 2016 – 2028
      • 6.3.9. Rest of Europe
        • 6.3.9.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
        • 6.3.9.2. Rest of Europe Market Revenue, By End User, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By End User, 2016 – 2028
      • 6.4.4. China
        • 6.4.4.1. China Market Revenue, By Product, 2016 – 2028
        • 6.4.4.2. China Market Revenue, By End User, 2016 – 2028
      • 6.4.5. Japan
        • 6.4.5.1. Japan Market Revenue, By Product, 2016 – 2028
        • 6.4.5.2. Japan Market Revenue, By End User, 2016 – 2028
      • 6.4.6. India
        • 6.4.6.1. India Market Revenue, By Product, 2016 – 2028
        • 6.4.6.2. India Market Revenue, By End User, 2016 – 2028
      • 6.4.7. South Korea
        • 6.4.7.1. South Korea Market Revenue, By Product, 2016 – 2028
        • 6.4.7.2. South Korea Market Revenue, By End User, 2016 – 2028
      • 6.4.8. South-East Asia
        • 6.4.8.1. South-East Asia Market Revenue, By Product, 2016 – 2028
        • 6.4.8.2. South-East Asia Market Revenue, By End User, 2016 – 2028
      • 6.4.9. Rest of Asia Pacific
        • 6.4.9.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
        • 6.4.9.2. Rest of Asia Pacific Market Revenue, By End User, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.5.2. Latin America Market Revenue, By Product, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By End User, 2016 – 2028
      • 6.5.4. Brazil
        • 6.5.4.1. Brazil Market Revenue, By Product, 2016 – 2028
        • 6.5.4.2. Brazil Market Revenue, By End User, 2016 – 2028
      • 6.5.5. Argentina
        • 6.5.5.1. Argentina Market Revenue, By Product, 2016 – 2028
        • 6.5.5.2. Argentina Market Revenue, By End User, 2016 – 2028
      • 6.5.6. Rest of Latin America
        • 6.5.6.1. Rest of Latin America Market Revenue, By Product, 2016 – 2028
        • 6.5.6.2. Rest of Latin America Market Revenue, By End User, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By End User, 2016 – 2028
      • 6.6.4. GCC Countries
        • 6.6.4.1. GCC Countries Market Revenue, By Product, 2016 – 2028
        • 6.6.4.2. GCC Countries Market Revenue, By End User, 2016 – 2028
      • 6.6.5. South Africa
        • 6.6.5.1. South Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.5.2. South Africa Market Revenue, By End User, 2016 – 2028
      • 6.6.6. Rest of Middle-East Africa
        • 6.6.6.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.6.2. Rest of Middle-East Africa Market Revenue, By End User, 2016 – 2028
  • Chapter No. 7 Defibrillators Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Technulogy Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8 Competitive Landscape
    • 8.1. Company Market Share Analysis – 2020
      • 8.1.1. Global Defibrillators Market: Company Market Share, 2020
      • 8.1.2. Global Defibrillators Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 8.1.3. Global Defibrillators Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Defibrillators Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9 Company Profiles
    • 9.1. Boston Scientific Corporation
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfulio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Medtronic Plc
    • 9.3. Abbott Laboratories
    • 9.4. Nihon Kohden Corporation
    • 9.5. Koninklijke Philips N.V.
    • 9.6. Biotronik
    • 9.7. LivaNova Plc
    • 9.8. Mediana Co. Ltd.
    • 9.9. BPL Medical Technulogies
    • 9.10. Schiller AG
  • Chapter No. 10 Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodulogy
    • 11.1. Research Methodulogy
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

List of Figures

FIG NO. 1. Market Attractiveness Analysis, By Product
FIG NO. 2. Market Attractiveness Analysis, By End User
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Defibrillators Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Product, 2020 & 2028
FIG NO. 7. Global Defibrillators Market for Implantable Cardioverter Defibrillators (ICDs), Revenue (USD Million) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Defibrillators Market for Implantable Cardioverter Defibrillators (ICDs), By Country, 2020 & 2028
FIG NO. 9. Global Defibrillators Market for External Defibrillators, Revenue (USD Million) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Defibrillators Market for External Defibrillators, By Country, 2020 & 2028
FIG NO. 11. Market Revenue Share, By End User, 2020 & 2028
FIG NO. 12. Global Defibrillators Market for Hospitals, Clinics and Cardiac Centers, Revenue (USD Million) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Defibrillators Market for Hospitals, Clinics and Cardiac Centers, By Country, 2020 & 2028
FIG NO. 14. Global Defibrillators Market for Prehospital Care Settings, Revenue (USD Million) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of Defibrillators Market for Prehospital Care Settings, By Country, 2020 & 2028
FIG NO. 16. Global Defibrillators Market for Public Access Markets, Revenue (USD Million) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Defibrillators Market for Public Access Markets, By Country, 2020 & 2028
FIG NO. 18. Global Defibrillators Market for Home Care Settings, Revenue (USD Million) 2016 – 2028
FIG NO. 19. Comparative Revenue Analysis of Defibrillators Market for Home Care Settings, By Country, 2020 & 2028
FIG NO. 20. Global Defibrillators Market for Alternate Care Facilities, Revenue (USD Million) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Defibrillators Market for Alternate Care Facilities, By Country, 2020 & 2028
FIG NO. 22. Global Defibrillators Market Revenue Share, By Region, 2020 & 2028
FIG NO. 23. North America Defibrillators Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 24. Porter’s Five Forces Analysis for Global Defibrillators Market
FIG NO. 25. PEST Analysis for Global Defibrillators Market
FIG NO. 26. Pricing Analysis for Global Defibrillators Market
FIG NO. 27. Value Chain Analysis for Global Defibrillators Market
FIG NO. 28. Company Share Analysis, 2020
FIG NO. 29. Radar Determinant Chart, 2019
FIG NO. 30. Company Strategic Developments – Heat Map Analysis
FIG NO. 31. Boston Scientific Corporation Business Segment Revenue Share, 2020 (%)
FIG NO. 32. Boston Scientific Corporation Geographical Segment Revenue Share, 2020 (%)
FIG NO. 33. Market Channels
FIG NO. 34. Marketing Channel Development Trend
FIG NO. 35. Growth in World Gross Product, 2008-2018
FIG NO. 36. Research Methodology – Detailed View
FIG NO. 37. Research Methodology
 


List of Tables 

TABLE NO. 1. Global Defibrillators Market: Snapshot
TABLE NO. 2. Quarterly Defibrillators Market Revenue By Region, 2020
TABLE NO. 3. Quarterly Defibrillators Market Revenue Forecast By Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Defibrillators Market for Implantable Cardioverter Defibrillators (ICDs), By Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Defibrillators Market for External Defibrillators, By Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Defibrillators Market for Hospitals, Clinics and Cardiac Centers, By Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Defibrillators Market for Prehospital Care Settings, By Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Defibrillators Market for Public Access Markets, By Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Defibrillators Market for Home Care Settings, By Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Defibrillators Market for Alternate Care Facilities, By Region, 2016 – 2028 (USD Million)
TABLE NO. 13. Global Defibrillators Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 14. North America Defibrillators Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 15. North America Defibrillators Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 16. North America Defibrillators Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 17. U.S. Defibrillators Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 18. U.S. Defibrillators Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 19. Canada Defibrillators Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 20. Canada Defibrillators Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 21. Mexico Defibrillators Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 22. Mexico Defibrillators Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 23. Drivers for the Defibrillators Market: Impact Analysis
TABLE NO. 24. Restraints for the Defibrillators Market: Impact Analysis
TABLE NO. 25. Major Buyers of Defibrillators
TABLE NO. 26. Distributors/Traders List of Defibrillators
TABLE NO. 27. Global Defibrillators Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 28. Global Defibrillators Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global Defibrillators Market was valued at USD 9,714.6 Million in 2020.

The global Defibrillators Market is expected to reach USD 12,552.2 Million by 2028, growing at a CAGR of 3.5% between 2021 to 2028.

Some of the key factors driving the global Defibrillators Market growth are increased health awareness, changing demographics and rising prevalence of non-communicable diseases

North America region held a substantial share of the Defibrillators Market in 2020. This surge can be credited to innovations in the field of healthcare and devices, enhanced obesity rate, well-established and advanced healthcare system and high prevalence of cardiovascular diseases, in the region.

Some of the major companies operating in the Defibrillators Market are Boston Scientific Corporation, Medtronic Plc, Abbott Laboratories, Nihon Kohden Corporation, Koninklijke Philips N.V., Biotronik, LivaNova Plc, Mediana Co. Ltd., BPL Medical Technologies and Schiller AG among others.

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +1 (844) 845-52454
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-52454
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social